Terms: = Cervical cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1 AND Treatment
3 results:
1. [treatment and prognosis analysis of 488 patients with FIGO 2018 stage Ⅲc squamous cervical cancer].
Feng T; Shou HF; Yuan SH; Tang HR; Lyu XJ; Yin ZM; Lou HM; Ni J
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):359-367. PubMed ID: 37217343
[No Abstract] [Full Text] [Related]
2. Tailoring adjuvant radiotherapy for stage IB-IIA node negative cervical carcinoma after radical hysterectomy and pelvic lymph node dissection using the GOG score.
Yeo RM; Chia YN; Namuduri RP; Yap SP; Soong YL; Yam PK; Lim TY; Khoo-Tan HS
Gynecol Oncol; 2011 Nov; 123(2):225-9. PubMed ID: 21782226
[TBL] [Abstract] [Full Text] [Related]
3. Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting.
Kelley KM; Rowan BG; Ratnam M
Cancer Res; 2003 Jun; 63(11):2820-8. PubMed ID: 12782587
[TBL] [Abstract] [Full Text] [Related]